A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

University of Antwerp, Antwerp (Belgium)
9 More presentations in this session

Doctor D. Lindholm (Norrtalje, SE)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation


